OEM News, People

CardioSight Names Steve Motes as CEO

Motes boasts over 25 years of medical device experience.

Author Image

By: Sam Brusco

Associate Editor

CardioSight, developer of an intra-cardiac visualization and interventional platform, has appointed Steve Motes as its new CEO, effective yesterday.
 
Motes boasts over 25 years of medical device experience. He was most recently CEO of Vascular Graft Solutions, a Tel Aviv, Israel-based startup. Before that, he was the U.S. VP of Acute MCS/ECMO at Abbott. He began his tenure at Abbott as a director of Mechanical Circulatory Support.
 
Motes also had careers at Edwards Lifesciences, Medtronic, and Dräger Medical.
 
“Steve’s broad background of medical device sales leadership, launching new products, commercializing acquired technologies, and his experience in running startup organizations while fundraising makes him the right leader at the right time for CardioSight,” said Attila Meretei, CEO of MedRes and CardioSight board member.
 
“We are thrilled to have Steve lead the team here at CardioSight,” said Dr. Pedro Del Nido, member of the board for CardioSight. “Steve’s many years as a market leader in cardiac devices, coupled with his most recent executive experience, aligns well with CardioSight as we look to navigate the next phase of our company. With Steve on board, we can begin taking those next critical steps towards regulatory approval and commercialization”.
 
CardioSight’s platform provides high-resolution, near-field visualization to guide surgical instruments delivered through its working channel and into the beating heart. It aims to allow direct visualization of target cardiac tissues and instrument/tissue interaction, opening the way to developing novel minimally invasive procedures.
 
“Prototype development at CardioSight has advanced to a stage where we needed a commercially oriented leader who can transform a working technology into a product that will equip surgeons with new capability to image the work field and guide procedures to faster and better outcomes. Steve is that talented leader,” said Carl Berke, Ph.D., Partner, Mass General Brigham Ventures and CardioSight board member.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters